نتائج البحث

Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.

• Authors : Veyssière, Maëva; Hammoudi, Nassim; Le Bourhis, Lionel

Subjects: FU77B4U5Z0 (Ustekinumab); 9RV78Q2002 (vedolizumab); Biomarkers

• Source: Journal of Crohn's and Colitis, 19 (9) (2025-09-28)

تفاصيل العنوان

Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction.

• Authors : Louis, Renaud; Lommatzsch, Marek; Jackson, David J

Subjects: 71492GE1FX (benralizumab); Antibodies, Monoclonal, Humanized; Anti-Asthmatic Agents

• Source: Clinical and Experimental Allergy, 55 (7), 521-531 (2025-07)

تفاصيل العنوان

Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World:The RAPID Global Registry

• Authors : Lugogo, Njira L.; Soler, Xavier; Gon, Yasuhiro

Subjects: Asthma; Asthma control; Disease burden

• Source: Lugogo, N L, Soler, X, Gon, Y, Côté, A, Hilberg, O, Xia, C, Zhang, Y, de Prado Gómez, L, Rowe, P J, Radwan, A, Jacob-Nara, J A, Deniz, Y & Peters, A T 2025, 'Baseline Characteristics of

تفاصيل العنوان

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

Subjects: Humans; Dermatitis; Atopic/therapy

• Source: 2025, 'Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce', Journal of the European Academy of

تفاصيل العنوان

Editorial comment on 'Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)'

• Authors : Cabrera-Perez, Javier S; Eigenmann, Philippe; Akenroye, Ayobami

Subjects: Antibodies, Monoclonal, Humanized / therapeutic use; Asthma / drug therapy; Antibodies, Monoclonal, Humanized / adverse effects

• Source: Pediatric Allergy and Immunology. 35

تفاصيل العنوان

Therapeutic sequencing in inflammatory bowel disease: Determining the optimal position of vedolizumab for long-term Crohn's disease control using real-world evidence.

• Authors : Louis, Edouard; Litkiewicz, Michal; Agboton, Christian

Subjects: 9RV78Q2002 (vedolizumab); Antibodies, Monoclonal, Humanized; Gastrointestinal Agents

• Source: United European Gastroenterology Journal, 12 (5), 574-584 (2024-06)

تفاصيل العنوان

Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics : post hoc analysis of a phase 3 study

• Authors : Ritchlin, Christopher T; Mease, Philip J; Boehncke, Wolf-Henning

Subjects: info:eu-repo/classification/ddc/616; Disease control; Domain

• Source: ISSN: 0770-3198 ; Clinical rheumatology, vol. 43, no. 8 (2024) p. 2551-2563.

تفاصيل العنوان

Severe Acute Generalized Exanthematous Pustulosis Successfully Treated by Spesolimab

• Authors : Russo, Giuseppe; Dumont, Shireen; Menzinger, Sébastien

Subjects: info:eu-repo/classification/ddc/616.07; info:eu-repo/classification/ddc/616; Humans

• Source: ISSN: 0001-5555 ; Acta dermato-venereologica, vol. 104 (2024) adv41311.

تفاصيل العنوان

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis:data from a randomised controlled trial

• Authors : Lend, Kristina; Lampa, Jon; Padyukov, Leonid

Subjects: Abatacept; Anti-Citrullinated Protein Antibodies; Arthritis

• Source: Lend, K, Lampa, J, Padyukov, L, Hetland, M L, Heiberg, M S, Nordström, D C, Nurmohamed, M T, Rudin, A, Østergaard, M, Haavardsholm, E A, Hørslev-Petersen, K, Uhlig, T, Sokka-Isler, T, Gudbjornsson,

تفاصيل العنوان

Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis

• Authors : Flohr, Carsten; Irvine, Alan D; Cork, Michael J

Subjects: Antibodies; Monoclonal; Humanized/therapeutic use

• Source: Flohr, C, Irvine, A D, Cork, M J, Simpson, E L, Wollenberg, A, Deleuran, M, Praestgaard, A, Thomas, R B & Rossi, A B 2023, 'Dupilumab improves patient-reported symptoms and health-related quality of

تفاصيل العنوان